Cadrenal Therapeutics, Inc.

US$0.98As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:CVKDHealthcare
Country USA
PE (Fwd) •••
TSR 4Y CAGR (63.02%)
Div yield —
ROE (275.16%)
Biotechnology
Beta (5Y) 1.96
PE TTM —
TSR TTM (92.83%)
Mkt cap US$3.496M
ROIC (173.61%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.933
(4.84%)
(77.85%)
Hold 7|9|1|0|3
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.02
0.02
0.02
0.02
(1.66%)
7.53%
8.97%
7.70%
Revenue$M
0.176
0.181
0.190
0.189
5.62%
8.49%
8.00%
9.26%
Peers (US$3.496M)
Cap (US$)
PE
3.410M
—
Capital
TTM
5Y
10Y
Leveragex
6.863
0.042
0.023
EBIT/Intx
0.343
0.154
0.168
Own earn%
(34.80)
6.52
9.80
Sh yield%
16.51
20.57
20.51
Owners
Insiders/Inst%
3.28
59.77
Short interest%
0.86
SBC / revenue%
5.20
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
17–22
$1 testx
—
Incr. ROIC%
5